Found 10 matching trials
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer PHASE2 To explore the efficacy and safety of chidamide combined with endocrine in ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors PHASE4 The trial used a multicenter, open, single-arm design in which patients wer...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy NA To explore the efficacy and safety of Chidamide combined with endocrine for...
Show More Location
天擄åøčæē¤å»é¢
Learn More & Join Trial
Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy PHASE2 This trial is a single-arm study. The purpose of the trial is to evaluate t...
Show More Location
Multiple Locations
Learn More & Join Trial
An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer PHASE2 This is a prospective, single center, single arm phase II study designed to...
Show More Location
Anyang Tumor Hospital
Learn More & Join Trial
Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer NA This is a Open-label study of chidamide in combination with fulvestrant for...
Show More Location
Liangning Tumor Hospital &Institute
Learn More & Join Trial
Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer PHASE2 evaluate the efficacy and safety of chidamide combined with fulvestrant for...
Show More Location
Multiple Locations
Learn More & Join Trial
Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor. PHASE2 The study is designed to explore the clinical benefit following treatment w...
Show More Learn More & Join Trial
Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer PHASE2 The purpose of the study is evaluate the efficacy and safety of tucidinosta...
Show More Location
Multiple Locations
Learn More & Join Trial
Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer PHASE2 This Phase ā
” study was designed to assess the efficacy and safety of the co...
Show More Location
Affiliated Tumor Hospital of Shantou University Medical College
Learn More & Join Trial